| Armistice Capital, Llc |
Non-Executive Director |
Avalo Therapeutics, Inc. (AVTX)
|
2022-03-14 |
$1936.30 |
-99.6% |
78
|
$151,946 |
| Armistice Capital, Llc |
Non-Executive Director |
Avalo Therapeutics, Inc. (AVTX)
|
2022-03-07 |
$1943.34 |
-99.6% |
177
|
$344,132 |
| Armistice Capital, Llc |
Non-Executive Director |
Avalo Therapeutics, Inc. (AVTX)
|
2022-02-25 |
$2300.01 |
-99.7% |
49
|
$111,806 |
| Armistice Capital, Llc |
Non-Executive Director |
Avalo Therapeutics, Inc. (AVTX)
|
2022-02-22 |
$2315.64 |
-99.7% |
100
|
$231,564 |
| Armistice Capital, Llc |
Non-Executive Director |
Avalo Therapeutics, Inc. (AVTX)
|
2022-01-20 |
$2533.72 |
-99.7% |
108
|
$274,486 |
| Armistice Capital, Llc |
Non-Executive Director |
Avalo Therapeutics, Inc. (AVTX)
|
2022-01-14 |
$2865.87 |
-99.8% |
158
|
$452,768 |
| Armistice Capital, Llc |
Non-Executive Director |
Avalo Therapeutics, Inc. (AVTX)
|
2022-01-11 |
$2870.76 |
-99.8% |
224
|
$642,931 |
| Armistice Capital, Llc |
Non-Executive Director |
Avalo Therapeutics, Inc. (AVTX)
|
2021-09-17 |
$6345.05 |
-99.9% |
1,979
|
$12,557,902 |
| Armistice Capital, Llc |
Non-Executive Director |
AYTU BIOSCIENCE, INC (AYTU)
|
2020-12-11 |
$120.00 |
-98.0% |
66,667
|
$8,000,004 |
| Armistice Capital, Llc |
Non-Executive |
ReShape Lifesciences Inc. (RSLS)
|
2020-12-04 |
$1205856.25 |
-100.0% |
0
|
$26,612 |
| Armistice Capital, Llc |
Non-Executive |
ReShape Lifesciences Inc. (RSLS)
|
2020-11-17 |
$1220582.40 |
-100.0% |
0
|
$4,112 |
| Armistice Capital, Llc |
Non-Executive |
ReShape Lifesciences Inc. (RSLS)
|
2020-11-10 |
$1038200.00 |
-100.0% |
0
|
$8,592 |
| Armistice Capital, Llc |
Non-Executive |
ReShape Lifesciences Inc. (RSLS)
|
2020-11-02 |
$1032400.00 |
-100.0% |
0
|
$11,036 |
| Armistice Capital, Llc |
Non-Executive |
ReShape Lifesciences Inc. (RSLS)
|
2020-09-23 |
$1180300.00 |
-100.0% |
0
|
$8,140 |
| Armistice Capital, Llc |
Non-Executive |
ReShape Lifesciences Inc. (RSLS)
|
2020-09-22 |
$1199106.06 |
-100.0% |
0
|
$13,645 |
| Armistice Capital, Llc |
Non-Executive |
ReShape Lifesciences Inc. (RSLS)
|
2020-09-16 |
$1087500.00 |
-100.0% |
0
|
$375 |
| Armistice Capital, Llc |
Non-Executive Director |
TENAX THERAPEUTICS, INC. (TENX)
|
2020-09-08 |
$2277.36 |
-99.8% |
20
|
$45,547 |
| Armistice Capital, Llc |
Non-Executive Director |
TENAX THERAPEUTICS, INC. (TENX)
|
2020-09-03 |
$2292.84 |
-99.8% |
54
|
$123,240 |
| Armistice Capital, Llc |
Non-Executive Director |
TENAX THERAPEUTICS, INC. (TENX)
|
2020-08-31 |
$2350.00 |
-99.8% |
20
|
$47,000 |
| Armistice Capital, Llc |
Non-Executive |
TENAX THERAPEUTICS, INC. (TENX)
|
2020-08-26 |
$2415.84 |
-99.8% |
22
|
$52,700 |
| Armistice Capital, Llc |
Non-Executive Director |
TENAX THERAPEUTICS, INC. (TENX)
|
2020-08-21 |
$2365.18 |
-99.8% |
195
|
$460,443 |
| Armistice Capital, Llc |
Non-Executive |
ReShape Lifesciences Inc. (RSLS)
|
2020-08-20 |
$906254.35 |
-100.0% |
0
|
$31,244 |
| Armistice Capital, Llc |
Non-Executive |
ReShape Lifesciences Inc. (RSLS)
|
2020-07-17 |
$870000.00 |
-100.0% |
0
|
$13,500 |
| Armistice Capital, Llc |
Non-Executive |
ReShape Lifesciences Inc. (RSLS)
|
2020-01-29 |
$2067700.00 |
-100.0% |
0
|
$21,390 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
-99.2% |
$-23,454,167 |
$23,635,115 |